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ABSTRACT 
 
Background:  Acute migraine attacks effect 18% of women in the United States, 
and six to seven percent of men.  The disabling nature of these attacks, in 
combination with their chronic patterns of occurrence, impact and disrupt multiple 
aspects of a person’s life.  There are many abortive medications available, but 
none are free from side effects.  Migraineurs continue to explore alternative 
treatment options for this continuous battle against acute migraine attacks.  This 
systematic review examines the efficacy of acupuncture for the treatment of an 
acute migraine attack when compared to a control.  The evidence was reviewed 
and evaluated using GRADE. 
 
Method:  A comprehensive review of the current medical literature was executed 
using PubMed, Web of Science, Medline, EBM Reviews, and CINHAL. 
 
Results:  Two studies were reviewed. One study compared acupuncture to sham 
acupuncture, and found acupuncture to be more effective at 2 and 4 hours after 
treatment, but not at earlier time points.  The other study compared acupuncture 
to a placebo sumatriptan and sumatriptan when given at first signs of an attack, 
and established acupuncture to be more successful than the placebo sumatriptan 
in preventing a full attack.   
 
Conclusion:  Due to an overall moderate GRADE of evidence, more research is 
needed before acupuncture merits a strong recommendation as an option for 
treatment of acute migraine attack.  However, acupuncture did demonstrate 
superiority in the treatment of an acute migraine attack when compared with a 
control, and should be considered as an alternative treatment option.   
 
Keywords:  Acupuncture, migraine, acute 
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INTRODUCTION 
Background 
A migraine is a neurovascular dysfunction involving the dilation of blood 
vessels innervated by the trigeminal nerve (Aminoff, 2009).  Eighteen percent of 
women in the United States, and six to seven percent of men suffer from 
migraines (Lipton, Stewart, Diamond, Diamond, & Reed, 2001).  These attacks 
are episodic in nature, causing a dull or throbbing pain that can be generalized, 
but is most often lateralized to one side of the head.  Nausea, vomiting, 
photophobia, phonophobia, anorexia, cognitive impairment, and blurred or other 
visual disturbances often accompany these menacing attacks (Aminoff, 2009).  
The combination of side effects is different for each person, so that every 
migraineur can endure his or her own personal flavor of migraine (Aminoff, 
2009). 
A migraine, not only affects an individual physically, but also has multiple 
other consequences.  A person’s entire life is interrupted when a migraine arises.  
Schedules are aborted, and responsibilities are put on hold as the migraineur 
flees society in search of a dark room devoid of noise.  This habitual practice 
induced by the cyclical nature of these attacks can distress a person’s whole life, 
therefore, greatly impacting a person’s interpersonal relationships, perceived 
quality of life, and emotional status (Leonardi, Raggi, Bussone, & D'Amico, 
2010).         
 Migraine attacks are usually triggered by a specific source.  The 
avalanche of symptoms can be prompted by stress, either physical or emotional, 
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missed meals, sleep disturbances (either too much or too little sleep), certain 
foods, alcohol, bright lights, loud noises, menstruation, and use of oral 
contraceptives (Aminoff, 2009).  Once initiated, the attack builds slowly, but 
demonstrates great stamina, and can persist for several hours (Aminoff 2009).   
 The key to successfully combating an acute migraine attack is early 
treatment.  There are a variety of abortive medications available.  For some 
suffering individuals, a simple analgesic like acetaminophen or Ibuprofen can 
alleviate a migraine if taken early when the first symptoms arise.  For many 
though, stronger artillery is necessary.   
One option is ergotamine, a vasoconstrictor. The ergot derivative 
dihydroergotamine is another possibility, but has the drawback of not being 
absorbed by the gastrointestinal tract, and therefore must be consumed through 
less popular routes via intranasal or intramuscular, subcutaneous, or intravenous 
injection.  The triptans, serotonin agonists, have proved to be the trendiest 
weaponry, and are prescribed more often than any other abortive migraine 
therapies (Gallagher 2009).  Triptans combat migraines by impeding the release 
of vasoactive peptides, stimulating vasoconstriction, and hindering pain pathways 
in the brainstem (Tfelt-Hansen, De Vries, and Saxena, 2000). 
 As the pain starts to dissolve a hope flickers, and begins to shape and 
form within the migraineur, that perhaps relief might actually be achieved at some 
time in the near future.  At this point these abortive medications may seem like 
small miracles perfectly packaged, and sent with care from the pharmaceutical 
companies, but in reality assuagement is not without side effects.  Ottervanger, 
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Valkenburg, Grobbee, and Stricker (1997) described some of the common side 
effects of subcutaneous sumatriptan as an injection site reaction, chest pressure 
or heaviness, flushing, weakness, drowsiness, dizziness, malaise, a feeling of 
warmth, and paresthesias.  While it was reported that these symptoms usually 
diminish within 30 minutes, many individuals might choose not to tolerate such 
symptoms for any length of time, leading them to search for other treatments to  
manage their migraines (Ottenvanger, 1997). 
 Could acupuncture be the answer to these migraineurs’ quest?  
Acupuncture has been practiced in China and other Asian countries for 
thousands of years, and is considered one of the oldest healing practices known.  
According to Traditional Chinese Medicine in order for health to be maintained 
within the body there must be balance between yin and yang, two internal, 
opposing yet indivisible forces (National Center for Complementary and 
Alternative Medicine (NCCAM), 2009).  Disease arises when there is an 
imbalance among these forces, resulting in the obstruction of the flow of qi (vital 
energy) along pathways in the body termed meridians.  Traditional Chinese 
Medicine accesses these meridians using acupuncture at certain points of the 
body to release the qi, thereby restoring balance (NCCAM, 2009).   
 Utilizing acupuncture to treat ongoing pain issues like chronic back pain 
and osteoarthritis has been a growing trend in the United States within recent 
years.  Many studies have been done in the U.S. and other parts of the world, 
investigating the use of acupuncture for migraines.  In 2009, Linde et al. 
published a meta-analysis evaluating acupuncture for migraine prophylaxis.  The 
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objectives of the review examined acupuncture versus no preventative treatment, 
acupuncture versus sham acupuncture, and lastly, acupuncture’s efficacy 
compared with other preventative interventions (Linde et al., 2009).   
After reviewing 22 trials, Linde et al. (2009) concluded that acupuncture 
was more effective when compared to no prophylactic treatment, and that 
according to the studies reviewed acupuncture was as effective, if not more so, 
than other preventative interventions.  However, not enough evidence was 
established to determine acupuncture’s superiority to sham acupuncture (Linde 
et al., 2009).  Now that acupuncture has been established as a treatment for 
migraine prevention through careful investigation, tireless review, and thorough 
analysis, the question remains as to whether acupuncture could be utilized to 
treat acute attacks. 
Purpose of the Study 
The purpose of this paper is to implement a systematic review of the 
current medical literature on the use of acupuncture for treatment of acute 
migraine attack when compared to a control, using the Grading of 
Recommendations Assessment, Development and Evaluation (GRADE) tool 
developed by the GRADE Working Group. 
METHOD 
 
A comprehensive review of the current medical literature was executed 
using PubMed, Web of Science, Medline, EBM Reviews, and CINHAL. These 
databases were accessed through the Pacific University Library system. The 
keywords applied in the search encompassed the combination of acupuncture, 
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migraine, and acute. Search limits were set, restricting the articles to those 
written in English, involving humans, and publication as of 2000 or more recent.  
Initially the search resulted in 3 to 15 articles depending on the database, 
however, many of these articles did not address acute migraine attacks.  All 
articles that did not focus on treatment of acute migraine attacks with 
acupuncture were disregarded, resulting in two randomized controlled trials to 
review.   
RESULTS  
Acupuncture For Treating Acute Attacks of Migraine: 
A Randomized Controlled Trial. 
The first study reviewed was a multicenter single-blind randomized 
controlled trial carried out in China, that investigated the use of acupuncture as 
treatment for an acute migraine attack.  The patients enrolled in the study were 
between the ages of 18-65 years old, and had been diagnosed with migraines 
according to the measures set by the International Headache Society which 
stipulates,  “One or more migraine attacks per month during the last 3 months, 
and acute migraine attacks for the last year (Li et al., 2009, p. 207).”  Other 
requirements for inclusion included that the patients were having an attack at the 
time of enrollment, and that they had not consumed any migraine medications 
within 24 hours of the onset of the attack.  Sham acupuncture was implemented 
as a placebo, applying the same filiform Huatao needles as the acupuncture 
group, but at nonacupoints (Ying et al., 2009).   
 10
The primary outcome was the difference between VAS (visual analog 
scale) scores from baseline and scores measured at 30 minutes, one, two, and 
four hours after treatment among the three groups.  Secondary outcomes 
included time of relief, extent of relief within 24 hours, use of medication, relapse 
or aggravation within 24 hours, and general evaluation (Ying et al., 2009).   
There were no significant differences in VAS scores among the three 
groups at 30 minutes (p=0.103), or one hour (p=0.166) after treatment. However, 
among the three groups there were significant differences found between the 
scores at two hours (p=0.032) and four hours (p=0.028) after treatment. From 
baseline to the second hour of treatment there was significant difference between 
the changes in VAS scores between the treatment and sham groups (p=0.14), 
but when the two sham groups were compared, no significant difference could be 
established (Ying et al., 2009).   
There was a significant difference among the three groups in the change 
between the VAS scores taken at baseline and at four hours after treatment 
(p<0.05).  In the fourth hour after treatment VAS scores had decreased 
considerably compared to baseline scores in all three groups, however, only the 
treatment group showed significant difference (p=0.012).  There was no 
significant difference measured in the two sham groups (p=0.600) (Ying et al., 
2009).  As for secondary outcomes, significant difference was found among the 
three groups in complete relief (p=0.003), relapse or aggravation over 24 hours 
(p=0.002), and in general effectiveness evaluation (p<0.001) (Ying et al., 2009). 
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Ying et al. (2009) concluded that acupuncture did demonstrate 
effectiveness in the treatment of acute migraine attacks at two and four hours 
after treatment, when compared with two sham acupuncture groups.  They 
maintain the idea that there are physiological effects at acupoints that cannot be 
reproduced at nonacupoints.  In the future they would like to see more research 
on acupuncture when used as a longer-term treatment for patients suffering from 
acute migraines (Ying et al., 2009). 
Acupuncture Versus Placebo Versus Sumatriptan For Early Treatment of 
Migraine Attacks: A Randomized Controlled Trial. 
The next study reviewed was a partially double-blind randomized 
controlled trial from Germany that investigated whether acupuncture was an 
effective treatment for acute migraine attacks when compared with sumatriptan 
and a placebo sumatriptan.  Patients between the ages of 18-65 years of age 
were recruited from two different hospitals in Germany.  Recruitment was done in 
two stages (Melchart et al., 2003).    
In the first stage, patients had to meet the requirement of the diagnosis of 
migraines using the criteria set by the International Headache Society, as 
explained above.  Potential patients were then screened by a neurologist to 
ensure that they could identify the initial predictive symptoms of a migraine.  It 
was also a requirement to have a clean ECG without any pathological signs.  In 
the second stage of recruitment, prescreened patients would then come to the 
hospital when having early symptoms of a migraine attack (Melchart et al., 2003).  
 12
The Heller scale, a 50 point scale that resembles the VAS, was used to 
assess severity of pain.  If the pain was rated at mild or less, the patient was 
included in the study.  Patients who had taken sumatriptan or ergotamine within 
the last 24 hours were omitted from the study (Melchart et al., 2003). 
Patients were randomized into three groups.  The first group was treated 
with acupuncture.  The second was treated with sumatriptan and the third group 
received a placebo sumatriptan.  The placebo sumatriptan was packaged 
identically to the sumatriptan, therefore, this part of the study was double blinded 
(Melchart et al., 2003). 
The primary outcome was the number of patients with whom a full 
migraine attack was prevented within 48 hours.  In the acupuncture and 
sumatriptan groups a second round of treatment was given to patients who 
developed a full migraine attack after the first treatment.  As for the placebo 
patients, sumatriptan was given when initial treatment of placebo failed (Melchart 
et al., 2003). 
In 21 of the 60 patients (35%) in the acupuncture group, a full migraine 
attack was prevented within 48 hours.  Twenty-one of the 58 patients (36%) in 
the sumatriptan group escaped the attack, while only 11 of the 61 (18%) 
individuals in the placebo group were that fortunate enough to evade an attack.  
A significant difference was determined between the placebo group and the 
acupuncture group (P=0.028).  For acupuncture versus placebo the relative risk 
of developing a full migraine attack was 0.79 (95% CI, 0.64-0.99).  When 
sumatriptan was compared to the placebo, the relative risk of having a full attack 
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was 0.78 (95% CI, 0.62-0.98).  The relative risk of a full attack for acupuncture 
versus sumatriptan was 1.03 (95% CI, 0.64-1.68).  No significant difference was 
found between acupuncture and sumatriptan, however, patients in the 
sumatriptan group evaded the attack longer (p=0.218).  In the sumatriptan group 
the average time of attack was 19.9 hours (95% CI, 10.9-28.8).  In the 
acupuncture group the average time to attack was 8.5 hours (95% CI, 0-17.8), 
while the placebo group averaged 4.6 hours (95% CI, 2.4-6.8) before a full attack 
(Melchart et al., 2003).   
Using the Heller scale, at one hour after treatment one (2%) patient in the 
acupuncture group was completely pain free, and six (10%) individuals in the 
sumatriptan group were pain free, but no one in the placebo group was free of 
pain.  For this first hour after treatment there was no significant difference found 
between acupuncture and sumatriptan (p=0.059), but there was a significant 
difference found between acupuncture and placebo (p=0.496) and sumatriptan 
between placebo (p=0.012) (Melchart et al., 2003).   
At two hours after treatment, fourteen of the study participants found their 
pain to be completely alleviated in the sumatriptan group, while only four 
members in the acupuncture group were free of pain.  At the two-hour time point 
a significant difference was found between acupuncture and sumatriptan 
(p=0.057).  However, the placebo group did not have any pain relief at two hours 
following treatment (Melchart et al., 2003).   
By six hours after treatment ten study participants in the acupuncture 
group, twenty in the sumatriptan group, and three in the placebo group had 
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experienced complete pain relief.  A significant difference was found between the 
acupuncture and sumatriptan groups (p=0.034), and between the acupuncture 
group and the placebo group (p=0.044).  A significant difference was found 
between the sumatriptan and placebo groups (p<0.001).  
One hundred eight patients had a full migraine attack despite their first 
allocated treatment.  Two hours after the second treatment of acupuncture four 
out of 31 (13%) patients experienced a relief of pain by 50% or more.  Seventeen 
of 31(55%) patients who received another dose of sumatriptan reported pain 
relief of 50% or more.  As for the patients in the placebo group who received a 
sumatriptan injection 37 out of 49 (80%) individuals reported a reduction in pain 
by 50% or more (Melchart et al., 2003).  
Adverse events were also accounted for.  Twenty-three people in the 
sumatriptan group reported side effects, while only 14 participants in the 
acupuncture group and 10 in the placebo group complained of adverse events.  
All three groups reported elevated blood pressure, 22 patients in the sumatriptan 
group, 13 in the acupuncture group, and 8 in the placebo group.  Four individuals 
in the sumatriptan group complained of chest pain, and 2 complained of heat 
sensation.  No patients from either the acupuncture or placebo groups 
experienced these side effects.  Two people in the sumatriptan group and only 
one person in the placebo group complained of dizziness or vertigo (Melchart et 
al., 2003).   
Melchart et al. (2003) concluded that both acupuncture and sumatriptan 
were more effective in preventing a full migraine attack than the placebo 
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sumatriptan.  The sumatriptan group proved to have more people pain free at two 
hours after treatment when compared with both the acupuncture and placebo 
groups.  Sumatriptan also demonstrated its superiority to acupuncture in relieving 
a migraine once the attack was in full force (Melchart et al., 2003). 
 
DISCUSSION 
Migraine attacks can be relentless, and disrupt many aspects of a 
person’s life including relationships, careers, and quality of life (Leonardi, Raggi, 
Bussone, & D'Amico, 2010).  There are many treatment options available, but all 
are accompanied by various degrees of side effects, and therefore migraineurs 
continue the pursuit of other alternatives.  This study reviewed two randomized 
controlled trials comparing acupuncture with a control to determine if 
acupuncture is effective in the treatment of acute migraine attacks.  
The primary outcome evaluated in this systematic review was decrease in 
pain.  The two trials measured this in different ways.  Ying et al. (2009) compared 
verum acupuncture to sham acupuncture examining a change in VAS scores 
from baseline to half an hour, one, two, and four hours after treatment.  
Acupuncture was found to be superior to sham acupuncture at two and four 
hours after treatment, but not at early time points of half an hour and one hour 
post treatment (Ying et al., 2009).   
Melchart et al. (2003) compared acupuncture with both sumatriptan and a 
placebo sumatriptan, observing the number of patients who found complete relief 
within 48 hours, evading a full attack when treated at the first signs of migraine.  
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Pain was assessed using the Heller scale, which is similar to the VAS scoring 
system.  However, this systematic review only inspects acupuncture versus 
placebo sumatriptan in the GRADE comparison of evidence.  Melchart et al. 
(2003) found that acupuncture was more successful in decreasing pain, with 
more people attack-free in 48 hours than the placebo group. It is also worth 
mentioning that just as many individuals were attack-free within 48 hours in the 
acupuncture group as the sumatriptan group (Melchart et al., 2003). 
Another outcome measured was pain relief after one hour of treatment.  
Acupuncture was not able to demonstrate superiority to sham acupuncture at this 
time point (Ying et al., 2009).  However, acupuncture did demonstrate more 
effectiveness than the placebo sumatriptan.  Another result to be noted is that 
acupuncture did prove to be as successful as sumatriptan in relieving pain at one 
hour after treatment (Melchart et al., 2003).  
Pain relief was also assessed at 2 hours post treatment.  At this time 
acupuncture was able to demonstrate better pain relief than sham acupuncture 
with a significant difference in change of VAS scores from baseline to two hours 
(Ying et al., 2009).  Melchart et al. (2003), measuring with the Heller scale 
showed acupuncture’s superiority to placebo sumatriptan with more people free 
of pain at two hours.  This evidence supports acupuncture as an effective 
treatment for an acute migraine attack, when compared to a control. 
This review also evaluated the need for additional treatment as another 
outcome.   Additional treatment in the verum acupuncture versus sham 
acupuncture study was defined as medication with no further clarification.  No 
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significant difference was found in the necessity of this further treatment between 
the acupuncture and two sham groups (Ying et al., 2009).  In the study 
comparing acupuncture to placebo sumatriptan, additional treatment was 
outlined as another round of acupuncture for those in the acupuncture group, and 
a sumatriptan injection for those unfortunate enough to be initially in the placebo 
group.  A significant difference was found between the treatment and control 
group in the amount of patients requiring more treatment (Melchant et al., 2003).   
Ying et al. (2009) carried out a randomized controlled trial with verum 
acupuncture as the treatment group and two sham acupuncture groups serving 
as controls.  By comparing the three groups, Ying et al. were able to demonstrate 
the superiority of verum acupuncture when compared to its control, but this study 
was not without limitations.  The first limitation to be noted was the inability to 
completely blind patients.   
While researchers took great care to ensure everything about the 
treatment versus control procedures were identical, implementing randomization 
and utilizing the same filiform Huatao needles and well-trained acupuncturists, 
complete blinding was virtually impossible.  When true acupuncture is preformed 
the patient senses de qi, a twinge or tingling sensation that occurs when the 
needles are inserted and rotated (Ying et al., 2009).  The patients in the 
treatment group experienced de qi, while the patients in the control groups did 
not, eliminating any true blinding of the subjects.  The individuals who analyzed 
the results were, nonetheless, blinded to patients’ allocated groups and their 
ascribed treatments, designating this study as single-blinded (Ying et al., 2009).   
 18
Another limitation of this study that cannot be overlooked is the patient 
population size.  While the groups demonstrated wonderful randomization with 
yet similar characteristics of age, diagnosis, and VAS scores at baseline, there 
were only 175 participants in the study.  A greater sample size would have 
strengthened the evidence of this study, and future studies should attempt to 
recruit more participants.  
The authors of this study also acknowledged two other limitations of their 
trial. One limitation being that there was no baseline values 4 weeks before 
randomization to compare, only the one baseline measured just before 
randomization.  The other limitation is the duration of time the patients in each 
group had been suffering from migraine attacks.  A significant difference was 
found between the groups, and the authors attributed this to the small sample 
size (Ying et al., 2009).  The limitations of the trial are reflected in the GRADE 
given to each outcome examined within the study.  
Melchart et al. (2003) conducted a well done randomized controlled trial 
that was not completely free of limitations either.  The limitations of this study are 
very comparable to those of the first study.  While the patients of the sumatriptan 
and placebo groups were blinded from each other, the acupuncture group was 
very much aware that they were receiving the traditional Chinese medicine and 
not the injection of sumatriptan.  In this way there was a lack of blinding.  The 
authors of the study acknowledged that a sham acupuncture control group would 
have strengthened their study (Melchart et al., 2003).   
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Much like the first study, this trial consisted of a small sample size totaling 
179 participants.  Melchart et al. (2003) also divulged that their patient population 
was quite a selected sample in that all participants were recruited from hospitals 
where they were seeking inpatient care.  A larger and less selective sample 
could have strengthened the evidence of this study.  The limitations of the trial 
are incorporated into the GRADE given to each of the outcomes discussed in the 
study.   
GRADE is a grading system used to assess and compare outcomes from 
different clinical trials to evaluate the strength of the evidence found.  There are 
four ratings that can be given to an outcome: very low, low, moderate, and high.  
All outcomes investigated by a randomized control trial started with a grade of 
high.  As the outcome is evaluated it can be down graded due to discrepancies in 
study quality, consistency, directness, precision, and publication bias.  An 
outcome that starts at high can only have points deducted, and not added.  Any 
outcome examined by a study that is not a randomized controlled trial starts with 
a grade of low.  This outcome cannot be further downgraded, but can gain points, 
increasing its mark by evidence strengthening effects like large magnitude, dose 
response, and confounders (Guyatt, Oxman, Vist, Kunz, Falck-Ytter, Alonso-
Coello, & Schünemann, 2008). 
This systematic review compares acupuncture with a control in two 
different randomized controlled trials to determine its effectiveness as a 
treatment for acute migraine attacks.  GRADE was used to evaluate the four 
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outcomes discussed above.  The GRADE table below illustrates how each 
outcome was graded. 
The primary outcome: decrease in pain, started with a grade of high, 
because it was investigated by two randomized control studies.  However, one 
point was deducted for study quality due to small sample size and incomplete 
blinding discussed in the limitations of each study.   No points were deducted for 
consistency, directness, precision, or publication bias.  The overall grade for this 
outcome is moderate.  According to the GRADE working group website the mark 
of moderate indicates: “further research is likely to have an important impact on 
our confidence in the estimate of effect and may change the estimate” (Guyatt, 
2008, p. 926).  
The outcome of “pain relief found at one hour after treatment” started with 
the initial grade of high, due to the randomized controlled trials.  A point was 
subtracted from study quality for the same limitations in the trials as discussed 
above.  A point was also withheld from consistency, because of the mixed results 
between sham acupuncture versus placebo sumatriptan.  At one hour after 
treatment, acupuncture was able to establish superiority over placebo 
sumatriptan, but not sham acupuncture.  Since no clear explanation can be 
recognized for these varied results, the outcome must be downgraded due to this 
inconsistency.  The final grade of evidence for this outcome is low.  According to 
the GRADE working group website low implies “further research is very likely to 
have an important impact on our confidence in the estimate of effect and is likely 
to change the estimate,” (Guyatt, 2008, p. 926). 
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“Pain relief at two hours after treatment” also started at a grade of high.  It 
too was downgraded under study quality due to the limitations of the trials as 
discussed above.  However, no points were withheld under consistency, 
directness, precision, or publication bias.  The overall grade of this outcome is 
moderate. 
The last outcome appraised was “need for additional medication.”  As with 
the other outcomes it started at high, because the study design utilized 
randomized controlled trials.  This outcome also lost a point for study quality due 
to the same discrepancies as discussed above.  Inconsistencies were found in 
the data between the two studies.  A significant difference was found in the need 
for additional treatment when acupuncture was compared to placebo 
sumatriptan, but no difference was established when acupuncture competed 
against sham acupuncture.  This unexplained variation of data resulted in a point 
deducted from consistency.  The grade of evidence for this outcome is low.   
The overall grade of evidence for this systematic review is moderate.  
While further research would increase confidence in the evidence, these 
outcomes were able to demonstrate that acupuncture is effective in treating 
acute migraine attacks when compared to a control.        
It would have been helpful to compare side effects of acupuncture with 
controls, but not enough data could be retrieved from the studies.  Ying et al. 
(2009) lists the number of each adverse event, but did not specify how many 
participants affected were from the treatment versus control groups.  This made it 
impossible to compare between studies.   
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It was interesting to exam the differences in adverse events that Melchart 
et al. (2003) reported between acupuncture, placebo sumatriptan, and 
sumatriptan.  There wasn’t a large difference between acupuncture and the 
placebo sumatriptan, but acupuncture did have fewer adverse events than 
sumatriptan.  While all three groups were shown to raise blood pressure in some 
patients, sumatriptan had a few patients who experienced chest pain, heat 
sensation, and dizziness or vertigo.  None of the acupuncture patients 
experienced these side effects, and only one patient in the placebo group 
experienced dizziness or vertigo (Melchart et al., 2003).  While these findings 
were not included in the GRADE evaluation of evidence, the results beautifully 
illustrate the drawbacks of standard treatment, and the necessity of an alterative 
treatment for acute migraine attacks, such as acupuncture.   
So what does this mean for migraineurs in the event of an acute migraine 
attack?  Acupuncture was shown to be superior to sham acupuncture in pain 
relief at two and four hours after treatment, better than placebo sumatriptan, and 
as effective as sumatriptan in preventing a full attack within 48 hours when 
treated at first signs of attack.  Acupuncture also had fewer side effects than 
sumatriptan.   
Due to an overall moderate GRADE of evidence, more research is needed 
before acupuncture merits a strong recommendation as an option for treatment 
of acute migraine attack.  However, acupuncture should not be completely 
omitted from the arsenal.  Acupuncture’s limited adverse events compared to 
standard treatment make it an attractive alternative tactic for many migraineurs 
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as they combat these chronic, life-distressing migraines one attack at a time.  
The benefits far outweigh the risks.  As for the future, it would be interesting to 
see the results from more studies comparing acupuncture to standard 
treatments, with larger sample sizes.         
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